Abstract
High-dose chemotherapy with autologous bone marrow or peripheral stem cell support is frequently used for the treatment of high-risk pediatric solid tumors. The gained experience with these treatments runs parallel with a considerable decrease on the procedure- related complications. These strategies have demonstrated its efectivity in the treatment of high-risk neuroblastoma as well as in refractory or relapsed germ cell tumors. There are also evidences showing that its use in high-risk Ewing's sarcoma, and in chemosensitive relapsed or metastatatic brain tumors, contributes to ameliorate the dismal prognosis of these patients.
| Translated title of the contribution | Intensive chemotherapy with stem cell support in non-hematological pediatric solid tumors: State of the art |
|---|---|
| Original language | Spanish |
| Pages (from-to) | 5-10 |
| Number of pages | 6 |
| Journal | Clinical and Translational Oncology |
| Volume | 3 |
| Issue number | 1 |
| Publication status | Published - Jan 2001 |
